These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 3743936)

  • 1. [Evaluation of the hemodynamic effects and anti-arrhythmic activity of propafenone: from new frontiers to clinical verification].
    Lotto A; Finzi A
    G Ital Cardiol; 1986 Apr; 16(4):333-5. PubMed ID: 3743936
    [No Abstract]   [Full Text] [Related]  

  • 2. [Propafenone: a new anti-arrhythmic agent for the treatment of ventricular ectopic beats].
    Molinis G; Valente M; Tuniz D; Maisano G
    Cardiologia; 1982; 27(2):211-7. PubMed ID: 6927434
    [No Abstract]   [Full Text] [Related]  

  • 3. [The anti-arrhythmic effects and electrophysiological actions of propafenone].
    Zheng DS; Wang BY
    Zhonghua Yi Xue Za Zhi; 1985 Jul; 65(7):418-20. PubMed ID: 3938327
    [No Abstract]   [Full Text] [Related]  

  • 4. [Anti-arrhythmic effects of propafenone in coronary patients with ventricular arrhythmias].
    Fiol M; Palma JL; Bayés de Luna A; Aza V; Sadurní J
    Rev Esp Cardiol; 1984; 37(3):196-200. PubMed ID: 6505351
    [No Abstract]   [Full Text] [Related]  

  • 5. [Observations on the anti-arrhythmic effects of propafenone].
    Ku FS
    Zhonghua Nei Ke Za Zhi; 1982 Nov; 21(11):658-61. PubMed ID: 7166067
    [No Abstract]   [Full Text] [Related]  

  • 6. [Profile of a new anti-arrhythmic agent: propafenon. I. Electrophysiologic characterization].
    Disertori M; Vergara G; Dal Forno P; Inama G; Furlanello F
    Boll Soc Ital Cardiol; 1981; 26(1):75-85. PubMed ID: 7340862
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effects on the systemic and coronary circulation of a new IC-group anti-arrhythmia agent: propafenone. Hemodynamic study of 10 patients in the basal state and under auricular electric stimulation, before and after the intravenous injection of propafenone].
    Fernandez F; Boyibanga J; Vrancea F; Maarek-Charbit M; Genet P; Gay J
    Ann Cardiol Angeiol (Paris); 1986 Feb; 35(2):119-22. PubMed ID: 3707011
    [No Abstract]   [Full Text] [Related]  

  • 8. [Propafenone--a new antiarrhythmic agent. Clinical experience].
    Kozák P; Stárek A; Hes I; Spacek R
    Cas Lek Cesk; 1985 Mar; 124(13):407-10. PubMed ID: 3891090
    [No Abstract]   [Full Text] [Related]  

  • 9. Propafenone for the treatment of severe ventricular arrhythmias.
    Rabkin SW; Rotem CE; Boroomand-Rashti K; Bar-Shlomo B
    Can Med Assoc J; 1984 Sep; 131(6):601-3. PubMed ID: 6478345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Oral propafenone in chronic ventricular arrhythmias. Prospective evaluation with the Holter monitor].
    Sánchez Domínguez J; Roldán I; Navarro A; Villa JG; Urbina FJ; Barciela R; Barras C
    Rev Clin Esp; 1985 Nov; 177(8):372-5. PubMed ID: 3836459
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical experience with the antiarrhythmic propafenone (Rytmonorm)].
    Stejfa M; Spác J; Vítovec J; Havlát F
    Vnitr Lek; 1986 Apr; 32(4):393-7. PubMed ID: 3523975
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical evaluation of new antiarrhythmic agents: experiences with propafenone.
    Furlanello F; Disertori M; Vergara G; Guarnerio M; Dal Forno P; Padrini R; Gobbato S; Ferrari M
    Int J Clin Pharmacol Res; 1983; 3(2):101-5. PubMed ID: 6679511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic effects of antiarrhythmic drugs in acute myocardial infarction.
    Lotto A; Finzi A; Massari FM; Pagnoni F; Valentini R; Ambrosini F; Lo Masto M
    G Ital Cardiol; 1984 Oct; 14(10):762-7. PubMed ID: 6519385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experimental characterization of propafenone. Hemodynamic effects].
    Botti G; Aurier E; Finardi A
    G Ital Cardiol; 1984 May; 14(5):373-6. PubMed ID: 6468819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Oral propafenone in the long-term treatment of chronic ventricular arrhythmia].
    Vázquez García A; Marcos Sánchez F; Górgolas Hernández-Mora P; Durán Pérez-Navarro A
    Rev Clin Esp; 1986 Jun; 179(2):101. PubMed ID: 3738054
    [No Abstract]   [Full Text] [Related]  

  • 16. [Anti-arrhythmic effect of oral propafenone. Apropos of 70 cases].
    Coumel P; Leclercq JF; Assayag P; Maisonblanche P; Cauchemez B
    Arch Mal Coeur Vaiss; 1984 Nov; 77(12):1370-82. PubMed ID: 6439161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study of the electrophysiologic effects of propafenon in patients with cardiac pre-excitation].
    Disertori M; Vergara G; Inama G; Guarnerio M; Dal Forno P; Furlanello F
    Boll Soc Ital Cardiol; 1981; 26(11):1725-8. PubMed ID: 7349232
    [No Abstract]   [Full Text] [Related]  

  • 18. Propafenone--a new antiarrhythmic drug.
    Seipel L; Breithardt G
    Eur Heart J; 1980 Aug; 1(4):309-13. PubMed ID: 7023945
    [No Abstract]   [Full Text] [Related]  

  • 19. [Propafenone, a new anti arrhythmic agent].
    Ruipérez Abizanda JA; Campos Peris JV; Ruiz Ros JA; García García J; Jaen Armand E; Marco Quiles J; Martínez Jerez M; Salas Nieto J; Rodríguez Ruiz P; Pico Aracil F
    Rev Clin Esp; 1980 Sep; 158(6):279-81. PubMed ID: 7010468
    [No Abstract]   [Full Text] [Related]  

  • 20. [The treatment of arrhythmias in infants and children using propafenone].
    Dressler F; Grävinghoff L; Grütte E; Jüngst BK; Liersch R; Nomayo H; Puls I; Rautenburg HW; Schmaltz A; Schumacher G
    Monatsschr Kinderheilkd; 1985 Mar; 133(3):154-7. PubMed ID: 4010670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.